N.N.Blokhin Russian Cancer Research Center

What N.N.Blokhin Russian Cancer Research Center does

N.N. Blokhin National Medical Research Center of Oncology (ФГБУ «НМИЦ онкологии им. Н.Н. Блохина» Минздрава России) is a Federal State Budgetary Institution under the Ministry of Health of the Russian Federation, headquartered at Kashirskoye shosse, 23, Moscow. It is described as the largest national oncology center in Russia and Europe, and the only oncology clinic in Russia where all modern diagnostic and treatment modalities are available within a single facility. The center serves as a national referral institution, treating more than 200,000 patients annually from all regions of Russia and approximately 100 countries worldwide.

The center's service portfolio spans consultations and diagnostic intake, advanced imaging (MRI/CT, PET, scintigraphy), surgical oncology, drug therapy (chemotherapy, immunotherapy, targeted therapy), radiation therapy, bone marrow transplantation, vaccine therapy, day hospital care, rehabilitation, clinical trials, and a dedicated pediatric oncology and hematology institute. It also operates educational programs, dissertation councils, and a patent and inventions group. Supporting digital channels include an online patient personal account, an electronic reception system for patient feedback, and a multilingual website in 8 languages (Russian, English, German, French, Chinese, Arabic, Portuguese, Spanish).

The business model rests on three pillars: (1) state reimbursement under Russia's mandatory medical insurance (OMS) and high-tech medical care (VMP) programs via the 057/у referral pathway from regional oncologists; (2) paid services offered alongside public reimbursement; and (3) medical tourism services directed at international patients. The institution bears a recognized eponymous brand (N.N. Blokhin) and operates under the parallel trade name "Онкоцентр на Каширке." Leadership is headed by Academician of the Russian Academy of Sciences Ivan Sokrатовich Stiлиди as Director, with a senior team that includes multiple RAS academicians, corresponding members, and professors holding д.м.н. and к.м.н. credentials across surgical, radiation, pediatric, and translational oncology disciplines.

Name

N.N.Blokhin Russian Cancer Research Center

Legal name

ФГБУ «НМИЦ онкологии им. Н.Н. Блохина» Минздрава России

Website

https://ronc.ru

Company type

Private

Operating status

Operating

Headcount range

51–100 employees

Short description

N.N. Blokhin Russian Cancer Research Center is a federal government oncology hospital in Moscow and Europe's largest national cancer center, offering all modern diagnostics and treatments in one facility for 200,000+ patients annually from Russia and 100 countries.

Ownership category

akta.pro rank

Product category

Oncology Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Specialty (except Psychiatric and Substance Abuse) Hospitals (6223), Ambulatory Health Care Services (621)

SIC

Services-Hospitals (8060), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro industry

PRIMARYHLAFAHAC

Oncology & Cancer Specialty Hospitals

Healthcare & Life Sciences/Healthcare Providers & Systems/Specialty Hospitals & Inpatient Specialty Care

SECONDARYHLAFAAAM

Hospital-Integrated Cancer Centers (Acute Oncology Programs)

Healthcare & Life Sciences/Healthcare Providers & Systems/Acute Care Hospitals & Health Systems

SECONDARYHLAKAFAB

Medical Oncology

Healthcare & Life Sciences/Specialist Medical Practice/Hematology & Oncology

SECONDARYHLAKAFAC

Radiation Oncology

Healthcare & Life Sciences/Specialist Medical Practice/Hematology & Oncology

SECONDARYHLAKAFAG

Surgical Oncology

Healthcare & Life Sciences/Specialist Medical Practice/Hematology & Oncology

Keywords

• Oncology diagnostics
• Cancer treatment services
• Radiation therapy
• Bone marrow transplantation
• Pediatric oncology

Headquarters

HQ city

Moscow

HQ country

Russia

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Infrastructure, Technology or R&D, Operations, Supply Chain

Distribution channels3 records

Marketing channels3 records

Core offering

The N.N. Blokhin National Medical Research Center of Oncology is a federal government healthcare institution that provides comprehensive cancer diagnosis, treatment, rehabilitation, and clinical research in a single facility. Its offering spans outpatient consultations, advanced diagnostics (PET, MRI, CT, scintigraphy), all major treatment modalities (surgical, drug, radiation, bone marrow transplantation, vaccine therapy), pediatric oncology, and medical tourism services for international patients.

Product overview

N.N. Blokhin National Medical Research Center of Oncology (НМИЦ онкологии им. Н.Н. Блохина) is a federal state-funded healthcare institution that operates as Russia's largest national oncology center and the only oncology clinic in the country offering all modern diagnostic and treatment modalities in a single facility. The center provides a comprehensive range of medical services organized into distinct departments and offerings: consultations (outpatient and diagnostic reception), advanced diagnostics (MRI/CT, PET scans, scintigraphy), treatment (surgical and therapeutic oncology), rehabilitation, clinical trials, bone marrow transplantation, vaccine therapy, and day hospital care. The center serves as a national referral center, treating over 200,000 patients annually from all regions of Russia and 100 countries worldwide. The institution also maintains educational programs for medical professionals and conducts scientific research in oncology.

Differentiator

Problem solved

Functional benefit

Products and services

• Consultations and Diagnostic Reception (Консультативно-диагностический приём) Initial and follow-up medical consultations with oncologists and specialists, providing diagnostic assessment and treatment planning for cancer patients referred to the center.
• MRI/CT Diagnostics (МРТ/КТ) Advanced imaging services including magnetic resonance imaging and computed tomography for cancer diagnosis, staging, and treatment monitoring.
• PET Scanning (ПЭТ-исследования) Positron emission tomography services for cancer detection, staging, and treatment response evaluation.
• Scintigraphy (Сцинтиграфия) Nuclear medicine diagnostic imaging using radioactive tracers for detecting tumors and metastases.
• Surgical Oncology Treatment (Хирургическое лечение) Advanced surgical interventions for tumor removal, including oncological surgeries across multiple specialties.
• Drug Treatment (Лекарственное лечение) Chemotherapy, immunotherapy, targeted therapy, and other pharmacological cancer treatments delivered by oncology specialists.
• Radiation Therapy (Лучевая терапия) Radiotherapy services for cancer treatment using advanced radiation technologies and radiological treatment methods.
• Bone Marrow Transplantation (Трансплантация костного мозга) Hematopoietic stem cell transplantation services for blood cancers and related conditions.
• Vaccine Therapy (Вакцинотерапия) Cancer immunotherapy treatments including therapeutic vaccines administered to oncology patients.
• Day Hospital (Дневной стационар) Outpatient treatment facility for administering chemotherapy and other treatments without overnight hospitalization.
• Rehabilitation (Реабилитация) Post-treatment rehabilitation programs for cancer patients to restore function and quality of life.
• Clinical Trials (Клинические исследования) Participation in clinical research studies and trials for innovative cancer treatments and therapies.
• Research Institute of Pediatric Oncology and Hematology (НИИ детской онкологии и гематологии) Dedicated institute for pediatric oncology and hematology, providing comprehensive cancer care for children, including separate hospitalization pathways for minor patients.
• Medical Tourism Services (Медицинский туризм) Dedicated program coordinating cancer diagnostics and treatment for international patients, with multilingual support across Russian, English, German, French, Chinese, Arabic, Portuguese, and Spanish.

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Partnerships

Ten partnerships are on record, tiered core and minor.

• RUSSCO (Russian Society of Clinical Oncology)coreStrategic or Co-development PartnerProfessional oncology society for clinical guidelines and research collaboration.
• Фонд Блохина (Blokhin Foundation)coreStrategic or Co-development PartnerCharitable foundation named after N.N. Blokhin supporting patients and research.
• АОР (Association of Oncologists of Russia)coreStrategic or Co-development PartnerProfessional association of Russian oncologists for education and standards.
• Рак победим! (Cancer will be defeated!)minorOthersNon-profit organization supporting cancer patients.
• УчимЗнаем (We Teach Know)minorOthersOrganization providing educational support for seriously ill children.
• Анастасия (Anastasia Foundation)minorOthersCharitable foundation for children with serious illnesses.
• Искорки добра (Sparks of Kindness)minorOthersChildren's charitable organization.
• Зимний Бал (Winter Ball)minorOthersCharitable events for cancer patient support.
• ФРСИ (FRSI)minorOthersCharitable foundation Shamara for social support.
• Благотворительный фонд Помощь (Charitable Foundation Help)minorOthersCharitable foundation providing assistance to those in need.

Scale indicators3 records

Recent moves4 records

Expansion highlights5 records

Direct peers

• European Institute of Oncology (IEO): Milan-based comprehensive oncology center founded on a one-stop, all-cancer-types-in-one-place care model. Direct philosophical peer to Blokhin's integrated diagnostics-and-treatment-in-one-facility positioning.
• Memorial Sloan Kettering Cancer Center: U.S.-based comprehensive cancer hospital offering diagnostics, surgery, radiation, chemotherapy, BMT, and clinical trials in a single integrated setting. Closest peer in care-delivery model to Blokhin's all-in-one oncology approach.
• The Royal Marsden Hospital: UK's flagship specialist cancer hospital, NHS-funded but operating as a dedicated oncology institution with research and private-pay services. Comparable model as a publicly funded specialty cancer hospital with international patient services.
• MD Anderson Cancer Center: U.S. comprehensive cancer center and global benchmark for integrated oncology diagnostics, treatment, and research. Highly comparable as a one-stop multidisciplinary oncology institution, though U.S.-based and privately operated within a public university system.
• Charité Comprehensive Cancer Center: Major German university-affiliated oncology center integrating oncology care, clinical trials, and translational research across all tumor types. Comparable as a publicly funded, comprehensive-scope European oncology institution.
• N.N. Petrov National Medical Research Center of Oncology: Russian federal oncology research center in St. Petersburg, the closest domestic peer under the Ministry of Health. Comparable as a state-funded comprehensive oncology center delivering surgery, radiation, drug therapy, and research.
• Gustave Roussy Institute: Leading European comprehensive cancer center in France, frequently cited as one of Europe's largest oncology hospitals. Comparable as a flagship national/international referral center for all cancer types with research and teaching missions.
• Hertsen Moscow Oncology Research Center (NMIC Radiology): Another Moscow-based federal oncology center specializing in radiology and combined-modality treatment. Direct domestic competitor for Russian oncology referrals, with overlapping diagnostic and surgical capabilities.

Others

• European Organisation for Research and Treatment of Cancer (EORTC): Pan-European intergovernmental research organization running multi-center oncology clinical trials. Comparable as an enabler/ecosystem participant for oncology clinical research, though not a hospital operator.

Broad incumbents

• National Cancer Institute (NCI / NIH): U.S. federal government agency coordinating national cancer research, treatment standards, and clinical trials. Comparable as the public-sector anchor for national oncology policy and research funding, though operating more as a coordinator than a single hospital.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/ronc

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about N.N.Blokhin Russian Cancer Research Center